Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-10

Clinical Trial Update: Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating hydrocortisone, vitamin C, and thiamine for septic shock was terminated after phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCORTISONE (HYDROCORTISONE)
  • Thiamine (thiamine)
  • Vitamin C (ascorbic acid)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Septic Shock, Critical Illness | Phase 2, Phase 3 | Status: TERMINATED